Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease

NCT03149809 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

77

Enrollment

FED

Sponsor class

Conditions

Overactive Bladder
Parkinson Disease

Interventions

DRUG: solifenacin
BEHAVIORAL: Pelvic floor muscle exercise-based behavioral therapy

Sponsor

VA Office of Research and Development